Dermatomyositis Recruiting Phase 1 Trials for Tofacitinib (DB08895)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03002649Study of Tofacitinib in Refractory DermatomyositisTreatment